Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy

Tumor-specific CD8+T cells are exposed to persistent antigenic stimulation which induces a dysfunctional state called “exhaustion.” Though functioning to limit damage caused by immune response, T cell exhaustion leads to attenuated effector function whereby cytotoxic CD8+T cells fail to control tumo...

Full description

Bibliographic Details
Main Authors: Weiqin Jiang, Yinjun He, Wenguang He, Guosheng Wu, Xile Zhou, Qinsong Sheng, Weixiang Zhong, Yimin Lu, Yongfeng Ding, Qi Lu, Feng Ye, Hanju Hua
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.622509/full
_version_ 1819174193101537280
author Weiqin Jiang
Yinjun He
Wenguang He
Guosheng Wu
Xile Zhou
Qinsong Sheng
Weixiang Zhong
Yimin Lu
Yongfeng Ding
Qi Lu
Feng Ye
Hanju Hua
author_facet Weiqin Jiang
Yinjun He
Wenguang He
Guosheng Wu
Xile Zhou
Qinsong Sheng
Weixiang Zhong
Yimin Lu
Yongfeng Ding
Qi Lu
Feng Ye
Hanju Hua
author_sort Weiqin Jiang
collection DOAJ
description Tumor-specific CD8+T cells are exposed to persistent antigenic stimulation which induces a dysfunctional state called “exhaustion.” Though functioning to limit damage caused by immune response, T cell exhaustion leads to attenuated effector function whereby cytotoxic CD8+T cells fail to control tumor progression in the late stage. This pathway is a dynamic process from activation to “progenitor exhaustion” through to “terminally exhaustion” with distinct properties. With the rapid development of immunotherapy via enhancing T cell function, new studies are dissecting the mechanisms and identifying specific biomarkers of dynamic differentiation during the process of exhaustion. Further, although immune checkpoint inhibitors (ICIs) have achieved great success in clinical practice, most patients still show limited efficacy to ICIs. The expansion and differentiation of progenitor exhausted T cells explained the success of ICIs while the depletion of the progenitor T cell pool and the transient effector function of terminally exhausted T cells accounted for the failure of immune monotherapy in the context of exorbitant tumor burden. Thus, combination strategies are urgent to be utilized based on the reduction of tumor burden or the expansion of the progenitor T cell pool. In this review, we aim to introduce the concept of homeostasis of the activated and exhausted status of CD8+T cells in the tumor immune microenvironment, and present recent findings on dynamic differentiation process during T cell exhaustion and the implications for combination strategies in immune therapy.
first_indexed 2024-12-22T20:35:05Z
format Article
id doaj.art-b9eef6fa27524d06af123e637369daac
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-22T20:35:05Z
publishDate 2021-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-b9eef6fa27524d06af123e637369daac2022-12-21T18:13:29ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-02-011110.3389/fimmu.2020.622509622509Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to TherapyWeiqin Jiang0Yinjun He1Wenguang He2Guosheng Wu3Xile Zhou4Qinsong Sheng5Weixiang Zhong6Yimin Lu7Yongfeng Ding8Qi Lu9Feng Ye10Hanju Hua11Department of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, ChinaDepartment of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, ChinaDepartment of Radiology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, ChinaDepartment of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, ChinaDepartment of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, ChinaDepartment of Pathology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Surgical Oncology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Medical Oncology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaCollege of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, ChinaDepartment of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, ChinaTumor-specific CD8+T cells are exposed to persistent antigenic stimulation which induces a dysfunctional state called “exhaustion.” Though functioning to limit damage caused by immune response, T cell exhaustion leads to attenuated effector function whereby cytotoxic CD8+T cells fail to control tumor progression in the late stage. This pathway is a dynamic process from activation to “progenitor exhaustion” through to “terminally exhaustion” with distinct properties. With the rapid development of immunotherapy via enhancing T cell function, new studies are dissecting the mechanisms and identifying specific biomarkers of dynamic differentiation during the process of exhaustion. Further, although immune checkpoint inhibitors (ICIs) have achieved great success in clinical practice, most patients still show limited efficacy to ICIs. The expansion and differentiation of progenitor exhausted T cells explained the success of ICIs while the depletion of the progenitor T cell pool and the transient effector function of terminally exhausted T cells accounted for the failure of immune monotherapy in the context of exorbitant tumor burden. Thus, combination strategies are urgent to be utilized based on the reduction of tumor burden or the expansion of the progenitor T cell pool. In this review, we aim to introduce the concept of homeostasis of the activated and exhausted status of CD8+T cells in the tumor immune microenvironment, and present recent findings on dynamic differentiation process during T cell exhaustion and the implications for combination strategies in immune therapy.https://www.frontiersin.org/articles/10.3389/fimmu.2020.622509/fullCD8+ T cell exhaustionCD8+ T cell activationdifferentiationimmunotherapytumor microenvironment
spellingShingle Weiqin Jiang
Yinjun He
Wenguang He
Guosheng Wu
Xile Zhou
Qinsong Sheng
Weixiang Zhong
Yimin Lu
Yongfeng Ding
Qi Lu
Feng Ye
Hanju Hua
Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy
Frontiers in Immunology
CD8+ T cell exhaustion
CD8+ T cell activation
differentiation
immunotherapy
tumor microenvironment
title Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy
title_full Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy
title_fullStr Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy
title_full_unstemmed Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy
title_short Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy
title_sort exhausted cd8 t cells in the tumor immune microenvironment new pathways to therapy
topic CD8+ T cell exhaustion
CD8+ T cell activation
differentiation
immunotherapy
tumor microenvironment
url https://www.frontiersin.org/articles/10.3389/fimmu.2020.622509/full
work_keys_str_mv AT weiqinjiang exhaustedcd8tcellsinthetumorimmunemicroenvironmentnewpathwaystotherapy
AT yinjunhe exhaustedcd8tcellsinthetumorimmunemicroenvironmentnewpathwaystotherapy
AT wenguanghe exhaustedcd8tcellsinthetumorimmunemicroenvironmentnewpathwaystotherapy
AT guoshengwu exhaustedcd8tcellsinthetumorimmunemicroenvironmentnewpathwaystotherapy
AT xilezhou exhaustedcd8tcellsinthetumorimmunemicroenvironmentnewpathwaystotherapy
AT qinsongsheng exhaustedcd8tcellsinthetumorimmunemicroenvironmentnewpathwaystotherapy
AT weixiangzhong exhaustedcd8tcellsinthetumorimmunemicroenvironmentnewpathwaystotherapy
AT yiminlu exhaustedcd8tcellsinthetumorimmunemicroenvironmentnewpathwaystotherapy
AT yongfengding exhaustedcd8tcellsinthetumorimmunemicroenvironmentnewpathwaystotherapy
AT qilu exhaustedcd8tcellsinthetumorimmunemicroenvironmentnewpathwaystotherapy
AT fengye exhaustedcd8tcellsinthetumorimmunemicroenvironmentnewpathwaystotherapy
AT hanjuhua exhaustedcd8tcellsinthetumorimmunemicroenvironmentnewpathwaystotherapy